|50mg × 28 tablet||$ 2.50||$ 69.95||Buy Now!|
|50mg × 56 tablet||$ 2.78||$ 155.95||Buy Now!|
|50mg × 84 tablet||$ 2.46||$ 206.95||Buy Now!|
Generic Galvus is a medicine that contains the active substance vildagliptin. It is available as tablets (50 mg).
Vildagliptin is used to treat type-2 diabetes mellitus. It can be used in the following ways:
Vildagliptin is indicated in the treatment of type-2 diabetes mellitus in adults:
In adults, the recommended dose of Vildagliptin is:
one tablet in the morning (50 mg per day) when taken with a sulphonylurea. A lower dose of the sulphonylurea may also be considered to reduce the risk of hypoglycaemia (low blood glucose levels).
The daily dose should not exceed two tablets (100 mg). In patients with moderate or severe kidney problems, the recommended dose is 50 mg once daily.
Type-2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose (sugar) in the blood or when the body is unable to use insulin effectively. The active substance in Vildagliptin, vildagliptin, is a dipeptidyl-peptidase-4 (DPP-4) inhibitor. It works by blocking the breakdown of ‘incretin’ hormones in the body. These hormones are released after a meal and stimulate the pancreas to produce insulin. By increasing levels of incretin hormones in the blood, vildagliptin stimulates the pancreas to produce more insulin when blood glucose levels are high. Vildagliptin does not work when the blood glucose is low. Vildagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of the hormone glucagon. Together, these processes reduce blood glucose levels and help to control type-2 diabetes.
The most common side effect with Vildagliptin (seen in between 1 and 10 patients in 100) is dizziness. For the full list of all side effects reported with Vildagliptin, including side effects occurring when Vildagliptin is taken with other antidiabetes medicines, see the package leaflet.
Vildagliptin must not be used in people who are hypersensitive (allergic) to vildagliptin or any of the other ingredients. Because vildagliptin has been associated with liver problems, patients should have tests to check their liver function before treatment with Vildagliptin and at regular intervals during treatment.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.